{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:38:30Z","timestamp":1769042310294,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017K1A3A1A12073341"],"award-info":[{"award-number":["NRF-2017K1A3A1A12073341"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["14-2017-009"],"award-info":[{"award-number":["14-2017-009"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40261-018-0708-3","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T06:15:24Z","timestamp":1538374524000},"page":"1179-1188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9597-6310","authenticated-orcid":false,"given":"Yeon-Hee","family":"Baek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0542-2758","authenticated-orcid":false,"given":"Sang Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9878-4779","authenticated-orcid":false,"given":"In-Sun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6678-0941","authenticated-orcid":false,"given":"Han Eol","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7525","authenticated-orcid":false,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"issue":"suppl 2","key":"708_CR1","doi-asserted-by":"publisher","first-page":"s144","DOI":"10.1086\/428055","volume":"41","author":"R Owens","year":"2005","unstructured":"Owens R, Ambrose P. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41(suppl 2):s144\u201357.","journal-title":"Clin Infect Dis"},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/archinternmed.2012.3717","volume":"172","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Steinman M, Caplan C. Geographic variation in outpatient antibiotic prescribing among older adults. Arch Intern Med. 2012;172:1465\u201371.","journal-title":"Arch Intern Med"},{"key":"708_CR3","unstructured":"FDA. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. In: Drugs, editor. Silver Spring: U.S. Food and Drug Administration; 2016."},{"issue":"3","key":"708_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/ICO.0b013e31815dcfc4","volume":"27","author":"A Al-Amri","year":"2008","unstructured":"Al-Amri A. Corneal perforation associated with topically applied gatifloxacin. Cornea. 2008;27(3):370\u20131.","journal-title":"Cornea"},{"issue":"1","key":"708_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1442-9071.2007.01427.x","volume":"35","author":"N Samarakoon","year":"2007","unstructured":"Samarakoon N, Harrisberg B, Ell J. Ciprofloxacin induced toxic optic neuropathy. Clin Exp Ophthalmol. 2007;35(1):102\u20134.","journal-title":"Clin Exp Ophthalmol"},{"key":"708_CR6","first-page":"1","volume":"131","author":"D Han","year":"2012","unstructured":"Han D, Szabo A. Flashes, floaters, and oral fluoroquinolones. Arch Ophthalmol. 2012;131:1\u20133.","journal-title":"Arch Ophthalmol"},{"key":"708_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2165\/00003495-200161060-00004","volume":"61","author":"A Smith","year":"2001","unstructured":"Smith A, Pennefather P, Kaye S, Hart C. Fluoroquinolones: place in ocular therapy. Drugs. 2001;61:747\u201361.","journal-title":"Drugs"},{"key":"708_CR8","volume-title":"Retina","author":"S Ryan","year":"2006","unstructured":"Ryan S. Retina. 4th ed. Philadelphia: Elsevier\/Mosby; 2006.","edition":"4"},{"issue":"5","key":"708_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000055619","volume":"32","author":"M Ivanisevi\u0107","year":"2000","unstructured":"Ivanisevi\u0107 M, Boji\u0107 L, Eterovi\u0107 D. Epidemiological study of nontraumatic phakic rhegmatogenous retinal detachment. Ophthalmic Res. 2000;32(5):237\u20139.","journal-title":"Ophthalmic Res"},{"issue":"0710","key":"708_CR10","first-page":"PMC3275330","volume":"2010","author":"S Fraser","year":"2010","unstructured":"Fraser S, Steel D. Retinal detachment. BMJ. Clin Evid. 2010;2010(0710):PMC3275330.","journal-title":"Clin Evid."},{"issue":"11","key":"708_CR11","doi-asserted-by":"publisher","first-page":"e80174","DOI":"10.1371\/journal.pone.0080174","volume":"8","author":"SJ Park","year":"2013","unstructured":"Park SJ, Choi N-K, Park KH, Woo SJ. Five year nationwide incidence of rhegmatogenous retinal detachment requiring surgery in Korea. PLos One. 2013;8(11):e80174.","journal-title":"PLos One"},{"issue":"8","key":"708_CR12","first-page":"515","volume":"88","author":"C Gelston","year":"2013","unstructured":"Gelston C. Common eye emergencies. Am Family Physician. 2013;88(8):515\u20139.","journal-title":"Am Family Physician"},{"issue":"1","key":"708_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14192\/kjnic.2014.19.1.29","volume":"19","author":"Y Lee","year":"2014","unstructured":"Lee Y, Kim YA, Song W, Lee H, Lee HS, Jang SJ, et al. Recent trends in antimicrobial resistance in intensive care units in Korea. Korean J Nosocomial Infect Control. 2014;19(1):29\u201336.","journal-title":"Korean J Nosocomial Infect Control"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2012.383","volume":"307","author":"M Etminan","year":"2012","unstructured":"Etminan M, Forooghian F, Brophy J, Bird ST, Maberley D. Oral fluoroquinolones and the risk of retinal detachment. JAMA. 2012;307:1414\u20139.","journal-title":"JAMA"},{"key":"708_CR15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dku507","volume":"70","author":"CSL Chui","year":"2015","unstructured":"Chui CSL, Wong ICK, Wong LYL, Chan EW. Association between oral fluoroquinolone use and the development of retinal detachment: a systematic review and meta-analysis of observational studies. J Antimicrob Chemother. 2015;70:971\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"708_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","volume":"7","author":"J Hallas","year":"1996","unstructured":"Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7(5):478\u201384.","journal-title":"Epidemiology"},{"issue":"11","key":"708_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s40264-013-0085-z","volume":"36","author":"KB Pouwels","year":"2013","unstructured":"Pouwels KB, Visser ST, Bos HJ, Hak E. Angiotensin-converting enzyme inhibitor treatment and the development of urinary tract infections: a prescription sequence symmetry analysis. Drug Saf. 2013;36(11):1079\u201386.","journal-title":"Drug Saf"},{"issue":"1","key":"708_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12874-017-0457-7","volume":"18","author":"Y Takeuchi","year":"2018","unstructured":"Takeuchi Y, Shinozaki T, Matsuyama Y. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies. BMC Med Res Methodol. 2018;18(1):4.","journal-title":"BMC Med Res Methodol"},{"key":"708_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2288-14-66","volume":"14","author":"NL Pratt","year":"2014","unstructured":"Pratt NL, Ilomaki J, Raymond C, Roughead EE. The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study. BMC Med Res Methodol. 2014;14:66.","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"708_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","volume":"11","author":"K Yoshida","year":"2015","unstructured":"Yoshida K, Solomon DH, Kim SC. Active-comparator design and new-user design in observational studies. Nat Rev Rheumatol. 2015;11(7):437\u201341.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"708_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/pds.3623","volume":"23","author":"K Eftekhari","year":"2014","unstructured":"Eftekhari K, Ghodasra DH, Haynes K, Chen J, Kempen JH, VanderBeek BL. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiol Drug Saf. 2014;23(7):745\u201352.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"708_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40264-014-0138-y","volume":"37","author":"D Fife","year":"2014","unstructured":"Fife D, Zhu V, Voss E, Levy-Clarke G, Ryan P. Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases. Drug Saf. 2014;37(3):171\u201382.","journal-title":"Drug Saf"},{"key":"708_CR23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1214\/aos\/1176350933","volume":"16","author":"P Hall","year":"1988","unstructured":"Hall P. Theoretical comparison of bootstrap confidence intervals. Ann Stat. 1988;16:927\u201353.","journal-title":"Ann Stat"},{"issue":"4","key":"708_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jamaophthalmol.2015.6205","volume":"134","author":"F Raguideau","year":"2016","unstructured":"Raguideau F, Lemaitre M, Dray-Spira R, Zureik M. Association between oral fluoroquinolone use and retinal detachment. JAMA Ophthalmol. 2016;134(4):415\u201321.","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"708_CR25","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1093\/jac\/dku145","volume":"69","author":"CS Chui","year":"2014","unstructured":"Chui CS, Man KK, Cheng CL, Chan EW, Lau WC, Cheng VC, et al. An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study. J Antimicrob Chemother. 2014;69(9):2563\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"708_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1128\/AAC.39.2.513","volume":"39","author":"J Child","year":"1995","unstructured":"Child J, Andrews JM, Wise R. Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin. Antimicrob Agents Chemother. 1995;39(2):513\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"708_CR27","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1128\/AAC.36.11.2444","volume":"36","author":"JH Johnson","year":"1992","unstructured":"Johnson JH, Cooper MA, Andrews JM, Wise R. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin. Antimicrob Agents Chemother. 1992;36(11):2444\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"708_CR28","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1001\/jama.2013.280500","volume":"310","author":"B Pasternak","year":"2013","unstructured":"Pasternak B, Svanstrom H, Melbye M, Hviid A. Association between oral fluoroquinolone use and retinal detachment. JAMA. 2013;310:2184\u201390.","journal-title":"JAMA"},{"issue":"12","key":"708_CR29","first-page":"1764","volume":"42","author":"F Pea","year":"2016","unstructured":"Pea F, Viale P. Intracellular pharmacokinetics of antibacterials and their clinical implications. Clin Infect Dis. 2016;42(12):1764\u201371.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"708_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/thx.2009.131532","volume":"65","author":"A Prayle","year":"2010","unstructured":"Prayle A, Watson A, Fortnum H, Smyth A. Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis. Thorax. 2010;65(7):654\u20138.","journal-title":"Thorax"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1128\/AAC.42.6.1417","volume":"42","author":"W Liu","year":"1998","unstructured":"Liu W, Liu QF, Perkins R, Drusano G, Louie A, Madu A, et al. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials. Antimicrob Agents Chemother. 1998;42:1417\u201323.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"708_CR32","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1128\/AAC.47.5.1621-1629.2003","volume":"47","author":"S Bronner","year":"2003","unstructured":"Bronner S, Jehl F, Peter J-D, Ploy M-C, Renault C, Arvis P, et al. Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrob Agents Chemother. 2003;47(5):1621\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"708_CR33","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1128\/AAC.44.6.1674-1679.2000","volume":"44","author":"N Morlet","year":"2000","unstructured":"Morlet N, Graham GG, Gatus B, Mclachlan AJ, Salonikas C, Naidoo D, et al. Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis. Antimicrobial Agents Chemother. 2000;44(6):1674\u20139.","journal-title":"Antimicrobial Agents Chemother"},{"key":"708_CR34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0002-9394(14)70486-6","volume":"122","author":"DV Alfaro","year":"1996","unstructured":"Alfaro DV, Hudson SJ, Rafanan MM, Moss ST, Levy DP. The effect of trauma on the ocular penetration of intravenous ciprofloxacin. Am J Ophthalmol. 1996;122:678\u201383.","journal-title":"Am J Ophthalmol"},{"issue":"1\u20132","key":"708_CR35","first-page":"12","volume":"111","author":"N Feltgen","year":"2016","unstructured":"Feltgen N, Walter P. Rhegmatogenous retinal detachment\u2014an ophthalmologic emergency. Dtsch Arztebl Int. 2016;111(1\u20132):12\u201322.","journal-title":"Dtsch Arztebl Int"},{"key":"708_CR36","volume-title":"Retina","author":"SJ Ryan","year":"2006","unstructured":"Ryan SJ, Wilkinson C, Hinton D, Wilkinson C. Retina. 4th ed. Philadelphia: Elsevier Mosby; 2006.","edition":"4"},{"key":"708_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/sj.eye.6700197","volume":"16","author":"NG Ghazi","year":"2002","unstructured":"Ghazi NG, Green WR. Pathology and pathogenesis of retinal detachment. Eye. 2002;16:411\u201321.","journal-title":"Eye"},{"issue":"7","key":"708_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","volume":"32","author":"EC Lai","year":"2017","unstructured":"Lai EC, Pratt N, Hsieh CY, Lin SJ, Pottegard A, Roughead EE, et al. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies. Eur J Epidemiol. 2017;32(7):567\u201382.","journal-title":"Eur J Epidemiol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-018-0708-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0708-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0708-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T01:29:49Z","timestamp":1662168589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-018-0708-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-0708-3","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"assertion":[{"value":"1 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by a Grant funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) founded by the Ministry of Education (Grant no: NRF-2017K1A3A1A12073341) and the Seoul National University Bundang Hospital (SNUBH) Research Fund (Grant no: 14-2017-009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Yeon-Hee Baek, Sang Jun Park, Sohyun Jeong, In-Sun Oh, Han Eol Jeong, Kyu Hyung Park, and Ju-Young Shin, declare no competing interests, including specific financial interests and relationships and affiliations relevant to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures in this study were in accordance with the 1964 Helsinki declaration (and its amendments). This study was approved by the Institutional Review Board (IRB) of SNUBH (IRB no: X-1710-429-908),which waived the requirement for informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}